Drug
MT 201
MT 201: highest development phase Phase 1, developed by Mirador Therapeutics, Inc.. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Mirador Therapeutics, Inc.
Trials
| Drug | Phase | Indication |
|---|---|---|
| MT-201 NCT07219368 | Phase 1 |
Latest
No recent events.
Follow MT 201 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.